Related Experiment Video
Updated: May 26, 2026

Isolation of Atrial Myocytes from Adult Mice
Published on: July 25, 2019
Endothelial actions of atrial and B-type natriuretic peptides
1Physiologisches Institut der Universität Würzburg, Würzburg, Germany. michaela.kuhn@mail.uni-wuerzburg.de
Insights
Atrial natriuretic peptide (ANP) increases endothelial permeability via GC-A receptors, impacting blood pressure and volume. This study clarifies ANP
Area of Science:
- Cardiovascular Physiology
- Endothelial Biology
- Molecular Signaling
Background:
- Atrial natriuretic peptide (ANP) regulates blood pressure and volume homeostasis.
- The role of ANP's GC-A receptor in endothelial cells is debated, with conflicting reports on its effects on permeability and angiogenesis.
- Previous in vitro studies showed both pro- and anti-angiogenic properties of ANP.
Purpose of the Study:
- To investigate the in vivo role of endothelial GC-A signaling in ANP's actions.
- To clarify the functional relevance of ANP's interaction with endothelial GC-A receptors in the microcirculation.
- To differentiate between physiological and pharmacological effects of NP/GC-A signaling.
Main Methods:
- Generated mice with endothelial cell-specific inactivation of the GC-A gene using loxP/Cre-mediated recombination.
- Studied the effects of ANP on endothelial albumin permeability in the skin and skeletal muscle microcirculation.
- Reviewed recent advancements in endothelial NP/GC-A signaling in pulmonary and systemic circulation.
Main Results:
- Endothelial GC-A activation by ANP increases albumin permeability in skin and skeletal muscle microcirculation.
- This ANP-induced permeability is crucial for the hormone's hypovolemic and hypotensive effects.
- B-type natriuretic peptide (BNP) may exert paracrine effects, aiding endothelial regeneration in ischemic muscle.
Conclusions:
- Endothelial GC-A signaling mediates ANP's effects on microvascular permeability and systemic hemodynamics.
- Discrepant findings on ANP's endothelial actions may stem from different experimental contexts (in vitro vs. in vivo, physiological vs. pharmacological).
- Understanding endothelial NP/GC-A signaling offers potential therapeutic strategies for vascular and regenerative medicine.
Abstract:
The cardiac hormone atrial natriuretic peptide (ANP) is critically involved in the maintenance of arterial blood pressure and intravascular volume homeostasis. Its cGMP-producing GC-A receptor is densely expressed in the microvascular endothelium of the lung and systemic circulation, but the functional relevance is controversial. Some studies reported that ANP stimulates endothelial cell permeability, whereas others described that the peptide attenuates endothelial barrier dysfunction provoked by inflammatory agents such as thrombin or histamine. Many studies in vitro addressed the effects of ANP on endothelial proliferation and migration. Again, both pro- and anti-angiogenic properties were described. To unravel the role of the endothelial actions of ANP in vivo, we inactivated the murine GC-A gene selectively in endothelial cells by homologous loxP/Cre-mediated recombination. Our studies in these mice indicate that ANP, via endothelial GC-A, increases endothelial albumin permeability in the microcirculation of the skin and skeletal muscle. This effect is critically involved in the endocrine hypovolaemic, hypotensive actions of the cardiac hormone. On the other hand the homologous GC-A-activating B-type NP (BNP), which is produced by cardiac myocytes and many other cell types in response to stressors such as hypoxia, possibly exerts more paracrine than endocrine actions. For instance, within the ischaemic skeletal muscle BNP released from activated satellite cells can improve the regeneration of neighbouring endothelia. This review will focus on recent advancements in our understanding of endothelial NP/GC-A signalling in the pulmonary versus systemic circulation. It will discuss possible mechanisms accounting for the discrepant observations made for the endothelial actions of this hormone-receptor system and distinguish between (patho)physiological and pharmacological actions. Lastly it will emphasize the potential therapeutical implications derived from the actions of NPs on endothelial permeability and regeneration.
Related Concept Videos
Hormonal Regulation of Blood Pressure
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Antihypertensive Drugs: Action of β1 Blockers
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Heart Failure II: Pathophysiology

